Caren Deardorf

Companies

• Crinetics PharmaceuticalsBoard member Mar 14, 2022 to now¹
• Magenta TherapeuticsChief Commercial Officer Jul 8, 2021 to Dec 2, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMagenta Therapeutics DNTH19,762 shares³$1.5M at $74.77Nov 30, 2022
• Crinetics Pharmaceuticals0 shares⁴Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Returned to company 5,925 shares at $85.00 of Crinetics Pharmaceuticals⁴
• Sep 1, 2026Returned to company 16,300 shares at $85.00 of Crinetics Pharmaceuticals⁴
• Jun 18, 2026Granted 5,925 shares of Crinetics Pharmaceuticals⁵
• Jun 11, 2025Granted 6,900 shares of Crinetics Pharmaceuticals⁶
• Jun 7, 2024Granted 3,400 shares of Crinetics Pharmaceuticals⁷
• Jun 16, 2023Granted 6,000 shares of Crinetics Pharmaceuticals⁸
• Nov 30, 2022Granted 3,000 shares at $0.94 of Magenta Therapeutics³
• May 31, 2022Granted 3,000 shares at $0.99 of Magenta Therapeutics⁹